ENPP1 inhibits the cGAS–STING pathway to mediate immune evasion in EGFR-TKI–resistant non–small cell lung cancer

免疫系统 癌症研究 免疫疗法 下调和上调 肺癌 生物 细胞 癌症免疫疗法 细胞毒性 癌症 免疫学 体内 免疫 免疫检查点 癌细胞 先天免疫系统 T细胞 医学 磷酸二酯酶 细胞外 细胞生长 酪氨酸激酶 信号转导 体外 转录组 激酶
作者
Chao Zhou,Yuqing Liu,Hongyu Liu,Shuyuan Wang,Huimin Lei,Yabin Tang,Yuqing Lou,Jun Lü,Liang Zhu,Baohui Han
出处
期刊:Cell Death & Differentiation [Springer Nature]
标识
DOI:10.1038/s41418-026-01876-6
摘要

Third-generation EGFR tyrosine kinase inhibitors (TKIs), such as osimertinib, have demonstrated promising clinical efficacy in the treatment of EGFR-mutant non-small cell lung cancer (NSCLC). Despite substantial progress with EGFR-TKIs, the development of acquired resistance remains a major clinical challenge. Notably, the addition of immune checkpoint blockade after TKI resistance has not resulted in significant survival benefits compared to chemotherapy. In this study, we performed a comprehensive transcriptomic analysis of established osimertinib-resistant tumor models and found that the expression of the ectonucleotide phosphodiesterase ENPP1, a key regulator of extracellular cGAMP signaling, was significantly upregulated in resistant tumors compared to the parental TKI-sensitive NSCLC tumors. Mechanistically, upregulated ENPP1 in resistant cells promoted the hydrolysis of extracellular cGAMP, suppressing the cGAS-STING pathway in immune cells and subsequently impairing immune cell activation and function, thereby promoting immune suppression and tumor progression. Genetic depletion or pharmacological inhibition of ENPP1 enhanced immune cell-mediated cytotoxicity against TKI-resistant tumor cells. Furthermore, the use of ENPP1 inhibitors both in vitro and in vivo enhanced immune cell activity and antitumor efficacy in TKI-resistant lung cancers with high ENPP1 expression. Importantly, these observations were further validated by paired clinical tumor samples, which demonstrated increased ENPP1 expression following the development of acquired EGFR-TKI resistance. Collectively, our study highlights a critical role for ENPP1 in mediating immune evasion through suppression of the cGAMP-STING pathway in the tumor immune microenvironment, supporting ENPP1 as a promising therapeutic target to enhance immunotherapy efficacy in EGFR-TKI-resistant NSCLC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CipherSage的应助被丁丁采纳,获得10
1秒前
清新的樱发布了新的文献求助10
1秒前
坚定的海露完成签到,获得积分0
1秒前
陈医生的步行实验完成签到,获得积分20
1秒前
吴慧琼发布了新的文献求助10
1秒前
饭遇碟完成签到 ,获得积分10
2秒前
Edgar完成签到,获得积分10
2秒前
2秒前
2秒前
Yuenna发布了新的文献求助10
2秒前
球球发布了新的文献求助10
2秒前
茧茧发布了新的文献求助10
2秒前
科研通AI6.2的应助被罗鑫采纳,获得10
2秒前
蓝天的应助被研友_ndvmV8采纳,获得10
2秒前
2秒前
小马甲的应助被摸鱼大王采纳,获得10
3秒前
jr完成签到,获得积分20
3秒前
小葱头完成签到,获得积分0
3秒前
4秒前
wuly发布了新的文献求助10
4秒前
4秒前
科目三的应助被073采纳,获得10
4秒前
4秒前
YoRHac完成签到,获得积分10
4秒前
炸鱼排完成签到,获得积分10
5秒前
skoal发布了新的文献求助10
5秒前
Echo完成签到 ,获得积分10
6秒前
yang完成签到,获得积分10
7秒前
大方铃铛完成签到,获得积分10
7秒前
斯文败类的应助被1mo采纳,获得30
7秒前
7秒前
Jun的应助被初景采纳,获得10
7秒前
ZZICU发布了新的文献求助20
7秒前
Murray发布了新的文献求助10
8秒前
活泼的筝发布了新的文献求助30
8秒前
Viper完成签到,获得积分10
8秒前
8秒前
9秒前
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161403
求助须知:如何正确求助?哪些是违规求助? 9556121
关于积分的说明 21732327
捐赠科研通 7751529
什么是DOI,文献DOI怎么找? 3427556
关于科研通互助平台的介绍 2552588
邀请新用户注册赠送积分活动 2471994